Literature DB >> 12419442

Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies.

K S Clifford Chao1, Mary Lin.   

Abstract

PURPOSE: Intensity-modulated radiotherapy for gynecologic malignancies requires proper knowledge of the volumes to be irradiated and accurate delineation of these volumes on a three-dimensional projection. In this study, assisted by lymphangiography (LAG), we derived guidelines for delineating nodal target volumes on CT. METHODS AND MATERIALS: Sixteen patients with cervical cancer who underwent radiotherapy between 1995 and 1999 at the Mallinckrodt Institute of Radiology were enrolled in the study. The initial 6 patients underwent bipedal LAG as part of the staging workup. Cross-sectional CT images were acquired and analyzed, and lymph node locations were described relative to the aorta, vena cava, common iliac, external iliac, and femoral vessels. The greatest distance from lymph node to vessel wall and pelvic sidewall was determined for each nodal group. This served as a guideline from which the clinical target volume (CTV) definitions were developed. This proposed CTV was then applied to CT scans of 10 patients to determine the amounts of normal tissues encompassed.
RESULTS: Nodal CTV guidelines were derived to cover 100% of LAG-avid lymph nodes. This CTV definition encompassed an average of 58.1 +/- 22.8 cm(3) (6.8% +/- 2.8% of total volume) small bowel, 28.4 +/- 19.2 cm(3) (4.2% +/- 3.2%) large bowel, 8.6 +/- 8.6 cm(3) (3.2% +/- 2.6%) bladder, and 1.6 +/- 3.1 cm(3) (1.0% +/- 1.7%) rectum. The absolute volume and fraction of normal tissues encompassed by CTV plus 1- or 2-cm margins were calculated.
CONCLUSION: This study presents the first time that three-dimensional lymph node mapping with the aid of LAG has been used to generate a nodal CTV guideline. This information may assist radiation oncologists in properly determining nodal target volumes and selecting a margin around the CTV for intensity-modulated radiotherapy.

Entities:  

Mesh:

Year:  2002        PMID: 12419442     DOI: 10.1016/s0360-3016(02)03040-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  [Clinical target volume : Principles and limits].

Authors:  T B Brunner; M Walke; P Hass
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

2.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

Review 3.  Squamous-cell carcinoma of the anus: progress in radiotherapy treatment.

Authors:  Rob Glynne-Jones; David Tan; Robert Hughes; Peter Hoskin
Journal:  Nat Rev Clin Oncol       Date:  2016-01-27       Impact factor: 66.675

4.  Dosimetric comparison between conventional and conformal radiotherapy for carcinoma cervix: Are we treating the right volumes?

Authors:  Jyotirup Goswami; Niladri B Patra; Biplab Sarkar; Ayan Basu; Santanu Pal
Journal:  South Asian J Cancer       Date:  2013-07

5.  CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients.

Authors:  Amir Shahram Yousefi Kashi; Samira Khaledi; Mohammad Houshyari
Journal:  Iran J Cancer Prev       Date:  2016-06-14

6.  Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06).

Authors:  Ji Hyeon Joo; Young Seok Kim; Byung Chul Cho; Chi Young Jeong; Won Park; Hak Jae Kim; Won Sup Yoon; Mee Sun Yoon; Ji-Yoon Kim; Jin Hwa Choi; Youngmin Choi; Joo-Young Kim
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

7.  Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial.

Authors:  Jin Huang; Fei Gu; Tianlong Ji; Jing Zhao; Guang Li
Journal:  Radiat Oncol       Date:  2020-07-29       Impact factor: 3.481

8.  Intensity-Modulated Radiation Therapy Versus 3D Conformal Radiotherapy for Postoperative Gynecologic Cancer: Are They Covering the Same Planning Target Volume?

Authors:  Jelena Lukovic; Nikhilesh Patil; David D'souza; Barbara Millman; Brian P Yaremko; Eric Leung; Frances Whiston; George Hajdok; Eugene Wong
Journal:  Cureus       Date:  2016-01-25

9.  Patterns of lymph node metastasis in locally advanced cervical cancer.

Authors:  Zhikai Liu; Ke Hu; An Liu; Jie Shen; Xiaorong Hou; Xin Lian; Shuai Sun; Junfang Yan; Fuquan Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.